Poland· PL-100062328

Epitoram

A topiramate product containing topiramatum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX11

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEpitoramATCN03AX11REGISTER NO.PL-100062328PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Topiramate is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX11 (topiramate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Topiramate · ATC N03AX11

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of topiramate costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.28 in France to $30.56 in United States — a ×24 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Topiramate · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • US United States$30.56 (acquisition cost)
  • CH Switzerland$4.55
  • IT Italy$2.28
  • ES Spain$2.09
  • FR France$1.28
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Topiramatum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
N03AX11
ATC class
Topiramate
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990649570
  • gtin
    05909990649587

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

279 interactions on record for topiramate.

Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Topiramate · interactions on record

279 records

  • 43 severe
  • 43 moderate
  • 163 info

Most severe, free to view

  • DicycloverineA03AA07severe
  • PropanthelineA03AB05severe
  • MepenzolateA03AB12severe
  • TrospiumA03AB20severe

30 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8b27d00c-bd6b-4b1d-887c-6b1f3ce5bb76
GET /v1/drugs/8b27d00c-bd6b-4b1d-887c-6b1f3ce5bb76?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909990649570 ¦ Rp ¦ 43956\n28 tabl.\n05909990649587 ¦ Rp ¦ 43957\n60 tabl.",
  "substance": "Topiramatum 50 mg",
  "common_name": "Topiramatum",
  "pl_product_id": "100062328",
  "pozwolenie_nr": "14666",
  "auth_procedure": "MRP",
  "authorisation_validity": "2023-12-07"
}

See everything about topiramate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.